- Thn trng vi ph n c thai hoc ang cho con b, tr em di 12 tui
As mentioned, a secondary analysis of an RCT assessing the cardiometabolic effects of exenatide in 40 people with schizophrenia 140 also looked at measures of cognition and psychosocial functioning (that is, Brief Assessment of Cognition in Schizophrenia, ReyOsterreith Complex Figure Test, Short-Form Health Survey, Personal and Social Performance Scale, Positive and Negative Syndrome Scale), but found no effect for this GLP-1RA compared with placebo over 3 months 133
It typically takes several weeks for patients to notice an improvement in their symptoms
During this time, adults taking a weight loss drug in clinical trials lost an average of about 10 percent of their starting body weight
In PP analysis, the patients who completed the study until the end of treatment were included in the analysis process